Skip to main content

Liver Metastases

  • Chapter
  • First Online:
Neutron Capture Therapy
  • 1957 Accesses

Abstract

Liver metastases are a frequent, often fatal complication in the natural history of many types of cancer, particularly in the digestive tract. When they are multiples and diffuse to both lobes of the liver, there is at present no valid cure as surgical resection is impossible, traditional radiotherapy is contraindicated because of the risk of irreversible radiation damage of the liver, and chemotherapy is usually ineffective. Other palliative therapeutic approaches, such as local ablation techniques, despite an apparent focal control, rarely demonstrate a survival benefit. Therefore, there is an urgent need to elaborate and apply new curative strategies for multiple liver metastases.

For these clinical situations we proposed and performed in two patients a radio-surgical procedure based on an extracorporeal BNCT of the isolated, blood-deprived and chilled liver, which is previously treated with a 10B compound. This method is intended for young patients with a liver-only disease after a radical resection of the primary tumor (colon-rectum carcinoma) and in a good state of health.

The advantages of this new approach are that the diseased organ can be directly and entirely exposed to a homogeneous neutron flux so that the dose of the absorbed radiation is the same in any known or unknown tumor nodule, and even single cells, depending merely on the B content that was accumulated. Any interference of irradiation with other tissues and organs is avoided; endothelial damage of vessels is reduced to a minimum.

Difficulties and limitations are also present. From the surgical point of view, the procedure imposes a liver auto-transplantation, which is not an easy task. Early in the follow-up of both patients, a post-irradiation syndrome appeared; it lasted some weeks and caused dramatic even if reversible effects. Recurrences occurred in our long-surviving patient at 33 months and caused his death 44 months after BNCT.

All these aspects of our clinical experience are presented and discussed, together with the technical issues we faced during the physical and biological preparatory phases of the project.

This research was performed with the dedicated work of many people. The most important contributions were by:

Pinelli T, Fossati F, Bortolussi S, Bruschi P, Prati U, Sgarella A, Bakeine GJ, Dionigi P, Ferrari C, Clerici AM, Zonta C, Cansolino L, Nano R, Barni S, Chiari P, and Mazzini G.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Edmondson HA, Peters RL (1982) Neoplasms of the liver. In: Schiff L, Schiff ER (eds) Diseases of the liver, 5th edn. JB Lippincott Company, Philadelphia, pp 1101–1157

    Google Scholar 

  2. Quigley JP, Sullivan LM, DeMarinis CM et al (1988) Functional role of specific secreted and cell surface molecules in tumour cell invasion and metastasis. In: Bock G, Whelan J (eds) Metastasis. Ciba foundation symposium 141. Wiley, Chichester, pp 22–47

    Google Scholar 

  3. Rodgers MS, McCall JL (2000) Surgery for colorectal liver metastases with hepatic lymph-node involvement: a systematic review. Br J Surg 87:1142–1155

    Article  PubMed  CAS  Google Scholar 

  4. Rosen ChB, Donohue JH, Nagorney DM (1995) Liver resection for metastatic colonic and rectal carcinoma. In: Cohen AM, Winawer SJ (eds) Cancer of the colon, rectum and anus. McGraw-Hill Inc, New York, pp 805–821

    Google Scholar 

  5. Grundmann RT, Hermanek P, Merkel S et al (2008) Arbeitsgruppe workflow diagnostik und therapie von lebermetastasen kolorektaler karzinome. Zentralbl Chir 133:267–284

    Article  PubMed  CAS  Google Scholar 

  6. Heslin MJ, Medina-Franco H, Parker M et al (2001) Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg 136:318–323

    Article  PubMed  CAS  Google Scholar 

  7. Yan TD, Padang R, Morris DL (2006) Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases. J Am Coll Surg 202:100–111

    Article  PubMed  Google Scholar 

  8. Saltz LB, Cox JV, Blanke C et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343:905–914

    Article  PubMed  CAS  Google Scholar 

  9. Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041–1047

    Article  PubMed  CAS  Google Scholar 

  10. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342

    Article  PubMed  CAS  Google Scholar 

  11. Balch CM, Urist MM, Soong SJ et al (1983) A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198:567–573

    Article  PubMed  CAS  Google Scholar 

  12. Harmantas A, Rotstein LE, Langer B (1996) Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: is there a survival difference? Meta-analysis of the published literature. Cancer 78:1639–1645

    Article  PubMed  CAS  Google Scholar 

  13. Chang AE, Schneider PD, Sugarbaker PH et al (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685–693

    Article  PubMed  CAS  Google Scholar 

  14. Rougier P, Laplanche A, Huguier M et al (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10:1112–1118

    PubMed  CAS  Google Scholar 

  15. Kemeny N, Huang Y, Cohen AM et al (1999) Hepatic artery infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039–2048

    Article  PubMed  CAS  Google Scholar 

  16. Kemeny NE, Seiter K (1995) Hepatic arterial chemotherapy. In: Cohen AM, Winawer SJ (eds) Cancer of the colon, rectum and anus. McGraw-Hill Inc, New York, pp 831–843

    Google Scholar 

  17. McKay A, Dixon E, Taylor M (2006) Current role of radiofrequency ablation for the treatment of colorectal metastases. Br J Surg 93:1192–1201

    Article  PubMed  CAS  Google Scholar 

  18. Navarra G, Ayav A, Weber JC et al (2005) Short- and long-term results of intraoperative radiofrequency ablation of liver metastases. Int J Colorectal Dis 20:521–528

    Article  PubMed  CAS  Google Scholar 

  19. Gennari L, Doci R, Bozzetti F et al (1985) Proposal for staging liver metastases. In: Hellman K, Eccles SA (eds) Treatment of metastases. Problems and prospects. Taylor & Francis, London, pp 37–40

    Google Scholar 

  20. Gennari L, Doci R, Bozzetti F et al (1986) Proposal for staging liver metastases. Recent Results Cancer Res 100:80–84

    Article  PubMed  CAS  Google Scholar 

  21. Nievaart VA, Moss RL, Kloosterman JL et al (2006) Design of a rotating facility for extracorporal treatment of an explanted liver with disseminated metastases by boron neutron capture therapy with an epithermal neutron beam. Radiat Res 166:81–88

    Article  PubMed  CAS  Google Scholar 

  22. Miller M, Quintana J, Ojeda J et al (2008) New irradiation facility for biomedical applications at the RA-3 reactor thermal column. Appl Radiat Isot. doi:10.1016/j.apradiso.2009.03.107

  23. Briesmeister JF (ed) (2000) MCNP – a general Monte Carlo n-particle transport code. Version 4c LA-13709-M Los Alamos National Laboratory

    Google Scholar 

  24. Bortolussi S, Altieri S (2007) Thermal neutron irradiation field design for boron neutron capture therapy of human explanted liver. Med Phys 34:4700–4705

    Article  PubMed  CAS  Google Scholar 

  25. Westcott CH, Walker WH, Alexander TK et al. (1958) Effective cross section and cadmium ratios for the neutron spectra of thermal reactors. In: Proceedings international conference on the peaceful uses of atomic energy, Geneva, P/202 70 (1959 New York)

    Google Scholar 

  26. Westcott CH (1960) Effective cross section of well moderated thermal reactor spectra. Report AECL No. 1101

    Google Scholar 

  27. Altieri S, Bortolussi S, Bruschi P et al (2008) Neutron autoradiography imaging of selective boron uptake in human metastatic tumours. Appl Radiat Isot 66:1850–1855

    Article  PubMed  CAS  Google Scholar 

  28. Wittig A, Michel J, Moss RL et al (2008) Boron analysis and boron imaging in biological materials for boron neutron capture therapy (BNCT). Crit Rev Oncol Hematol 68:66–90

    Article  PubMed  Google Scholar 

  29. Martin MS, Bastien H, Martin F et al (1973) Transplantation of intestinal carcinoma in inbred rats. Biomedicine 12:555–558

    Google Scholar 

  30. Ferrari C, Clerici AM, Mazzini G et al. (2006) The BNCT resistant fraction of cancer cells: an in vitro morphologic and cytofluorimetric study on a rat coloncarcinoma cell line. In: Nakagawa Y, Kobayashi T, Fukuda H (eds) Advances in neutron capture therapy 2006. In: Proceedings 12th international congress on neutron capture therapy, Takamatsu, 2006, p 98–101

    Google Scholar 

  31. Pinelli T, Zonta A, Altieri S et al. (2002) Taormina: from the first idea to the application to the human liver. In: Sawerwein W, Moss R, Wittig A (eds) Research and development in neutron capture therapy. Proceedings 10th international congress on neutron capture therapy, Essen, 2002, p 1065–1072

    Google Scholar 

  32. Ferrari C, Clerici AM, Zonta C et al. (2008) Boron neutron capture therapy of liver and lung coloncarcinoma metastases: an in vitro survival study. In: Zonta A, Altieri S, Roveda L et al. (eds) A new option against cancer. Proceedings 13th international congress on neutron capture therapy, Florence, 2008, p 331–336

    Google Scholar 

  33. Zonta A, Prati U, Roveda L et al (2006) Clinical lessons from the first applications of BNCT on unresectable liver metastases. J Phys Conf Ser 41:484–495

    Article  CAS  Google Scholar 

  34. Roveda L, Prati U, Bakeine J et al (2004) How to study boron distribution in liver metastases from colorectal cancer. J Chemiother 16(Suppl 5):15–18

    CAS  Google Scholar 

  35. Steffen R, Ferguson DM, Krom RAF (1989) A new method for orthotopic liver transplantation with arterial cuff anastomosis to the recipient common hepatic artery. Transplantation 47:166–168

    Article  Google Scholar 

  36. Pinelli T, Altieri S, Fossati F et al. (2001) Operative modalities and effects of BNCT on liver metastases of colon adenocarcinoma. A microscopical and ultrastructural study in the rat. In: Hawthorne MF et al. (eds) Frontiers in neutron capture therapy. Proceedings 8th international congress on neutron capture therapy, Los Angeles, 2001, p 1427–1440

    Google Scholar 

  37. Nano R, Barni S, Gerzeli G et al (1997) Histiocytic activation following neutron irradiation of boron-enriched rat liver metastases. Ann N Y Acad Sci 832:274–278

    Article  PubMed  CAS  Google Scholar 

  38. Nano R, Barni S, Chiari P et al (2004) Efficacy of boron neutron capture therapy on liver metastases of colon adenocarcinoma. Optical and ultrastructural study in the rat. Oncol Rep 11:149–153

    PubMed  Google Scholar 

  39. Michie HR, Manogue KR, Spriggs DR et al (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481–1486

    Article  PubMed  CAS  Google Scholar 

  40. Roveda L, Zonta A, Staffieri F et al (2009) Experimental modified orthotopic piggy-back liver autotransplantation. Appl Radiat Isot. doi:10.1016/j.apradiso.2009.03

  41. Zonta A, Pinelli T, Prati U et al (2009) Extra-corporeal liver BNCT for the treatment of diffuse metastases: what was learned and what is still to be learned. Appl Radiat Isot. doi:10.1016/j.apradiso.2009.03.087

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Altieri .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zonta, A., Roveda, L., Altieri, S. (2012). Liver Metastases. In: Sauerwein, W., Wittig, A., Moss, R., Nakagawa, Y. (eds) Neutron Capture Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31334-9_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-31334-9_28

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-31333-2

  • Online ISBN: 978-3-642-31334-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics